XXIII International Poxvirus, Asfarvirus, and Iridovirus Conference

NIAID资金的这一申请是为了帮助支持2020年XXIII国际 痘病毒、阿斯法尔病毒和虹彩病毒会议。本次会议是该领域的首要会议， 主要研究人员、博士后研究员和来自世界各地的学生一起研究 痘病毒学和其他大型DNA病毒。2020年会议将于2020年6月26日至6月30日在 宾夕法尼亚州费城该会议于1977年成立，每隔一年举行一次，其目的是 为科学家提供一个学术会议场所，交流这一重要领域的思想。会议平均 约200名参与者。虽然有其他更一般性的会议，高级首席研究员在 这个领域提出他们的数据，这次会议的重点是提供一个论坛，研究生和 博士后研究员相互介绍他们的工作，并建立调查。会议还旨在 提供机会，突出新的初级教师在该领域。大部分的介绍都是由 无论是研究生还是博士后研究员，在充满活力的讨论环境中， 交换。除了口头报告，学生和博士后研究员有机会， 在海报会议上展示他们的作品。因此，无论是在口头会议和海报会议，学生和后- 痘病毒学领域的博士研究员在展示他们的数据和接触方面获得了宝贵的经验， 这对他们的科学和职业发展都是有益的。从历史上看，会议地点 在北美和欧洲之间。然而，2018年的会议在会议历史上第一次被 在亚洲举行。2020年会议自2014年以来首次重返北美（也是第一次 自2010年以来，美国）。选择2020年会议的地点是为了方便国家和 国际科学界。费城是很容易通过汽车或火车，并从周围的大 美国和世界各地通过费城国际机场直飞航班。 这个科学家群体在美国政府努力开发一种 有效应对有关天花、猴痘和其他新出现的痘病毒的公共卫生问题 疾病此外，随着一种基于痘病毒的重组疫苗的成功和痘病毒作为 由于在癌症治疗中使用溶瘤剂，因此迫切需要改进痘病毒作为疫苗载体 和治疗学。因此，第二十三届国际痘病毒、阿斯法尔病毒和虹彩病毒会议是非常重要的。 与NIAID的科学使命相关，并将为讨论新的认识提供场所 这些重要病毒的基本生物学，以及如何将它们转化为可以改善 人类健康和安全。

This application for NIAID funding is to help support selected expenses for the 2020 XXIII International Poxvirus, Asfarvirus and Iridovirus Conference. This conference is the premier meeting in the field that brings together principal investigators, postdoctoral fellows, and students from around the world who study poxvirology and other large DNA viruses. The 2020 meeting will be held on June 26 to June 30, 2020 in Philadelphia, PA. This conference, which is held every other year, was established in 1977 with the intent to provide a collegial meeting place for scientists to exchange ideas in this important field. The meeting averages around 200 participants. While there are other more general meetings where senior principal investigators in this field present their data, the focus of this meeting is to provide a forum where graduate students and postdoctoral fellows present their work to each other and established investigators. The meeting also aims to provide the opportunity to highlight new junior faculty in the field. The majority of presentations are given by either graduate students or post-doctoral fellows in a setting of vibrant discussions where ideas are exchanged. In addition to the oral presentations, students and post-doctoral fellows have the opportunity to present their work in poster sessions. Thus, both in oral sessions and poster sessions, students and post- doctoral fellows in the field of poxvirology gain valuable experience in presenting their data, as well as contacts that will be useful for advancing their science and their careers. Historically, the meeting location alternates between North America and Europe. However, for the first time in the meeting’s history, the 2018 meeting was held in Asia. The Conference for 2020 returns to North America for the first time since 2014 (and the first time in the U.S. since 2010). The location of the 2020 meeting was chosen to allow easy travel of the national and international scientific community. Philadelphia is easily accessible by car or train, and from around the greater United States and the world via direct flights to Philadelphia International Airport. This community of scientists have been playing a key role in the US government’s efforts to develop an effective response to the public health concerns regarding smallpox, monkeypox, and other emerging poxvirus diseases. In addition, with the success of a poxvirus-based recombinant vaccines and the use of poxviruses as oncolytic agents in the treatment of cancer, there is a critical need to improve poxviruses as vaccine vectors and therapeutics. Thus, the XXIII International Poxvirus, Asfarvirus and Iridovirus Conference is extremely relevant to the scientific mission of the NIAID and will provide a venue for discussions of new understandings of the basic biology of these important viruses and how they can be translated into regimens that can improve human health and safety.